Cris Constantinescu (University of Nottingham, Queen’s Medical Centre, UK), our Editor-in Chief of European Neurological Review, discusses the background and findings of his presentation comparing the immunomodulatory activity of mesenchymal stem cells from patients with secondary progressive multiple sclerosis (SPMS) and healthy volunteers against autologous immune cells (abstract available here).
Study support: Multiple Sclerosis Society of Great Britain and Northern Ireland.
Speaker disclosure: Cris Constantinescu has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
Share this Video
Related Videos In Neuroimmunology
Anthony Béhin, EAN 2023: Safety Profile Overview of Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases
Dr Anthony Béhin (University Hospitals Pitié Salpêtrière, Paris, France) discusses his abstract on the safety profile of anti-FcRn drugs, in particular efgartigimod, and anti-complement drugs in the treatment of IgG-mediated autoimmune diseases. The abstract ‘EPR-128 Safety Profile Overview of Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases’ was presented at the annual European Academy […]
Highlights from EAN 2023!
Michael Levy: Highlights from the 75th AAN Annual Meeting, 2023
Dr Michael Levy (Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA) provides his highlights from the 75th AAN Annual Meeting, 2023, in particular that this was the first year to have a myelin oligodendrocyte glycoprotein (MOG) antibody disease focus, with posters on two phase 3 trials, which are expected to be presented in 2026. Disclosures: […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!